| Cell line name |
CM |
|---|
| Accession |
CVCL_H246 |
|---|
| Resource Identification Initiative |
To cite this cell line use: CM (RRID:CVCL_H246) |
|---|
| Comments |
Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. |
|---|
| Disease |
Pancreatic insulinoma (NCIt: C95598)
Insulinoma (ORDO: Orphanet_97279) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Sex of cell |
Female |
|---|
| Age at sampling |
66Y |
|---|
| Category |
Cancer cell line |
|---|
| Publications | CLPUB00031
Nicolo Gueli, A. Toto, Giuseppe Palmieri, Giuseppe Carmenini, Andrea Delpino, Umberto Ferrini;
In vitro growth of a cell line originated from a human insulinoma.
J. Exp. Clin. Cancer Res. 6:281-285(1987) PubMed=10194529; DOI=10.1677/joe.0.1610059
Marco Giorgio Baroni, Maria Gisella Cavallo, Michael Mark, Laura Monetini, B. Stoehrer, Paolo Pozzilli;
Beta-cell gene expression and functional characterisation of the human insulinoma cell line CM.
J. Endocrinol. 161:59-68(1999) PubMed=17492774; DOI=10.1002/jcp.21135
Catherine Jonnakuty, Claudia Gragnoli;
Karyotype of the human insulinoma CM cell line -- beta cell model in vitro?
J. Cell. Physiol. 213:661-662(2007) PubMed=18384119; DOI=10.1002/jcp.21453
Claudia Gragnoli;
The CM cell line derived from liver metastasis of malignant human insulinoma is not a valid beta cell model for in vitro studies.
J. Cell. Physiol. 216:569-570(2008) PubMed=22538498; DOI=10.1159/000338793
Simona Grozinsky-Glasberg, Ilan Shimon, Hadara Rubinfeld;
The role of cell lines in the study of neuroendocrine tumors.
Neuroendocrinology 96:173-187(2012) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q54813694
|
|---|
| Polymorphism and mutation databases |
Cosmic; 1620108
Cosmic; 2530676
|
|---|
| Entry history |
|---|
| Entry creation | 11-Feb-2013 |
|---|
| Last entry update | 29-Jun-2023 |
|---|
| Version number | 13 |
|---|
